rs794728568
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000218.3(KCNQ1):c.557G>A(p.Gly186Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G186R) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.557G>A | p.Gly186Asp | missense_variant | Exon 3 of 16 | 1 | NM_000218.3 | ENSP00000155840.2 | ||
KCNQ1 | ENST00000335475.6 | c.176G>A | p.Gly59Asp | missense_variant | Exon 3 of 16 | 1 | ENSP00000334497.5 | |||
KCNQ1 | ENST00000496887.7 | c.296G>A | p.Gly99Asp | missense_variant | Exon 4 of 16 | 5 | ENSP00000434560.2 | |||
KCNQ1 | ENST00000646564.2 | c.478-12728G>A | intron_variant | Intron 2 of 10 | ENSP00000495806.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Long QT syndrome 1 Pathogenic:1
- -
not provided Pathogenic:1
- -
Congenital long QT syndrome Pathogenic:1
The p.Gly186Asp variant in KCNQ1 has been reported in the heterozygous state in 2 individuals with long QT syndrome (LQTS) and in the homozygous state in 1 indi vidual with Jervell and Lange-Nielsen syndrome (Vyas 2016a, Vyas 2016b, Itoh 201 6). Additionally, the variant segregated with prolonged QT interval in 5 individ uals from 2 families (Vyas 2016a, Vyas 2016b), and was absent from large populat ion studies. Computational prediction tools and conservation analysis suggest th at the variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Finally, several variants at the same positi on have been reported in individuals with LQTS (ClinVar variation IDs: 432149, 2 00894, 53065, 67082); however, their clinical significance is unknown due to lim ited available data. In summary, although additional studies are required to ful ly establish its clinical significance, the p.Gly186Asp variant is likely pathog enic. ACMG/AMP Criteria applied: PM2, PP1_Moderate, PP3, PS4_Supporting. -
Long QT syndrome Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 186 of the KCNQ1 protein (p.Gly186Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Jervell and Lange-Nielsen syndrome and long QT syndrome (PMID: 26669661, 27041150, 27485560, 34930020). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 207967). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function with a positive predictive value of 95%. This variant disrupts the p.Gly186 amino acid residue in KCNQ1. Other variant(s) that disrupt this residue have been observed in individuals with KCNQ1-related conditions (PMID: 22949429, 27041150, 27485560), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Cardiac arrhythmia Pathogenic:1
This missense variant replaces glycine with aspartic acid at codon 186 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with long QT syndrome in the heterozygous state and in an individual with Jervell and Lange-Nielsen syndrome in the homozygous state (PMID: 26669661, 27041150). This variant has been shown to segregate with long QT syndrome in two families (PMID: 27041150, 27485560). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at